Paul Zolkind

Medicine & Life Sciences

1. Squamous Cell Carcinoma of Head and Neck 100%
2. Head and Neck Neoplasms 84%
3. Squamous Cell Carcinoma 51%
4. Mouth 45%
5. T-Lymphocytes 41%
6. Neoplasms 40%
7. trametinib 39%
8. Immunotherapy 39%
9. pembrolizumab 36%
10. PNC-27 29%
11. Social Class 24%
12. Survival 21%
13. Clinical Trials 20%
14. Oropharyngeal Neoplasms 16%
15. Tumor-Infiltrating Lymphocytes 16%
16. Death Domain Receptors 15%
17. Tumor Biomarkers 15%
18. Mouth Neoplasms 15%
19. Tobacco Use 13%
20. Major Histocompatibility Complex 13%
21. Natural History 12%
22. Plasma Cells 12%
23. Cell Line 12%
24. Heterografts 12%
25. Vaccination 12%
26. Therapeutics 12%
27. Tumor Microenvironment 11%
28. Vaccines 11%
29. Mutation 11%
30. Antigens 10%
31. Necrosis 10%
32. Leukemia 10%
33. Cell Differentiation 10%
34. Emotions 10%
35. Cell Membrane 9%
36. Genotype 9%
37. Peptides 8%
38. Immune Evasion 8%
39. Biomarkers 7%
40. Intercellular Adhesion Molecule-1 7%
41. Epitopes 7%
42. Whole Exome Sequencing 7%
43. Incidence 6%